Alexia Carver, an undergraduate majoring in metallurgical engineering, spent ten weeks at Idaho National Laboratory (INL) ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Hemab Therapeutics named Syndax Pharmaceuticals alum Kate Madigan as chief medical officer. Kenvue has named Vikram ... voting in the 2024 election from a New York residence where he does not legally ...

We offer a range of highly regarded undergraduate, postgraduate, research, and short courses in biosciences, health sciences, medicine, psychology, and veterinary medicine. Our mission is to ...

Pheno Therapeutics Limited ... is targeted toward treatment of neurological diseases with high unmet medical need, with an initial focus on multiple sclerosis (MS). Demyelination in MS occurs ...

You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Sage Therapeutics belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same ...

Krishna Institute of Medical Sciences Ltd., incorporated in the year 1973, is a Small Cap company (having a market cap of Rs 24,334.45 Crore) operating in Hospitals & Allied Services sector. Krishna ...

Truist keeps a Hold rating on Sage Therapeutics (SAGE) after Zurzurvae’s commercial partner Biogen (BIIB) disclosed an unsolicited proposal to acquire the company for $7.22 per share.

On Friday, Sage Therapeutics Inc. (NASDAQ:SAGE) confirmed that Biogen Inc. (NASDAQ:BIIB) submitted an unsolicited, nonbinding proposal to acquire all of the outstanding shares of Sage Therapeutics ...